RESUMO
UNLABELLED: Parathyroidectomy, in any of its forms, is considered an effective short-term treatment of renal hyperparathyroidism in patients who are not being controlled with drugs. Nevertheless, the outcome in the medium and long term of the various surgical procedures is still unclear and seems a controversial issue. We conducted a prospective study of 15 patients undergoing subtotal parathyroidectomy who were followed up for a period of 48 months after surgery. All patients were included in hemodialysis programmes. Elevated levels of parathyroid hormone which did not decrease with drug therapy recommended parathyroidectomy. The aim of our study is to determine whether subtotal parathyroidectomy is an effective technique in the medium and long term. As regards the results obtained, the levels of parathyroid hormone and calcemia remarkably decreased during the follow-up period, if compared to pre-surgery levels. The level of alkaline phosphatase also showed a reduction and the "hungry bone effect" was observed. The phosphorus and Ca-P product levels only showed a significant reduction immediately after surgery but showed an increment from the first year after surgery onwards. Hemoglobin levels did not show any alteration after parathyroidectomy. In two patients we observed a relapse of hyperparathyroidism. The anatomopathological examination revealed nodular hyperplasia in most of the cases, including the two relapses. CONCLUSION: Subtotal parathyroidectomy is an effective surgical procedure in the medium-term treatment of renal hyperparathyroidism.
Assuntos
Hiperparatireoidismo Secundário/cirurgia , Paratireoidectomia , Adulto , Feminino , Seguimentos , Humanos , Hiperparatireoidismo Secundário/sangue , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Hormônio Paratireóideo/sangue , Estudos Prospectivos , Recidiva , Diálise Renal , Fatores de TempoRESUMO
INTRODUCTION: Cerebral metastases and the sequelae of their treatment are the major cause of neurological symptoms in patients with cancer. OBJECTIVE: In this article we review the oto-neuro-ophthalmological complications of the treatment of metastases with radiotherapy and/or chemotherapy. DEVELOPMENT: When speaking of the iatrogenic diseases caused by radiotherapy treatment of metastases, it is important to emphasize that the major complications of this form of treatment are seen in the long term, in general, months or years later. When dealing with incurable diseases, such as most metastatic cancers, the benefit/risk balance of each therapeutic option has to be taken into account. Thus we have a population of patients with symptoms secondary to metastatic involvement, and with an overall life expectancy which may be measured in months. The oto-neuro-ophthalmological toxicity of the chemotherapy may present as an infrequent and unexpected complication or as a usual, expected secondary effect of the drug used. A large variety of drugs are used for the systemic control of cancer (cystostatic drugs, hormones and modifiers of the biological response) which, in one way or another, may cause neurological signs. CONCLUSION: The increasingly frequent use of high dose chemotherapy and of the combined use of chemotherapy and radiotherapy mean that these types of toxicity have become common clinical syndromes in current oncological practices.
Assuntos
Antineoplásicos/efeitos adversos , Irradiação Craniana/efeitos adversos , Neoplasias de Cabeça e Pescoço/secundário , Neoplasias de Cabeça e Pescoço/terapia , Corticosteroides/efeitos adversos , Adulto , Antimetabólitos Antineoplásicos/efeitos adversos , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Antineoplásicos Alquilantes/efeitos adversos , Antineoplásicos Hormonais/efeitos adversos , Encéfalo/patologia , Encefalopatias/etiologia , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/secundário , Neoplasias Encefálicas/cirurgia , Catarata/etiologia , Quimioterapia Adjuvante/efeitos adversos , Criança , Neoplasias da Coroide/radioterapia , Neoplasias da Coroide/secundário , Terapia Combinada , Córnea/efeitos da radiação , Demência/etiologia , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Neoplasias de Cabeça e Pescoço/radioterapia , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Neoplasias Meníngeas/radioterapia , Neoplasias Meníngeas/secundário , Necrose , Cuidados Paliativos , Lesões por Radiação/etiologia , Radioterapia Adjuvante/efeitos adversos , Risco , Terapia de Salvação/efeitos adversos , Neoplasias da Base do Crânio/tratamento farmacológico , Neoplasias da Base do Crânio/radioterapia , Neoplasias da Base do Crânio/secundário , Neoplasias da Base do Crânio/cirurgia , Acidente Vascular Cerebral/etiologia , Transtornos da Visão/etiologiaRESUMO
Severe liver failure is a rare complication of erythropoietic protoporphyria (PEP), which is associated with a high rate mortality. Until now, 31 patients with this hepatic complication had underwent a liver transplantation, with a high rate of survival, but their long-term outcome is not well established. We report the first case in Spain of PEP in 59-year-old, whose acute liver failure was treated with liver transplantation, without postoperative complications. The patient is in good clinical condition 30 months later. Nevertheless during the first eleven months of follow-up the plasma levels of protoporphyrin remained elevated, which was accompanied of biochemical and histological evidence of relapse of the metabolic disease in the graft. Cases such as this stress the usefulness of liver transplantation, but also the need of more efficient measures to decrease the protoporphyrin levels before and after the transplant, in order to prevent hepatic and extrahepatic complications in these patients.
Assuntos
Falência Hepática Aguda/cirurgia , Transplante de Fígado , Porfiria Hepatoeritropoética/cirurgia , Biópsia , Colestase/etiologia , Terapia Combinada , Coproporfirinas/análise , Humanos , Fígado/patologia , Falência Hepática Aguda/diagnóstico , Falência Hepática Aguda/etiologia , Transplante de Fígado/patologia , Masculino , Pessoa de Meia-Idade , Porfiria Hepatoeritropoética/complicações , Porfiria Hepatoeritropoética/diagnóstico , Período Pós-Operatório , Protoporfirinas/análise , Recidiva , Transaminases/análiseAssuntos
Transfusão de Sangue Autóloga , Neoplasias/cirurgia , Animais , Perda Sanguínea Cirúrgica , Neoplasias Colorretais/mortalidade , Neoplasias Colorretais/cirurgia , Contraindicações , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Recidiva Local de Neoplasia/epidemiologia , Recidiva Local de Neoplasia/etiologia , Células Neoplásicas Circulantes , Complicações Pós-Operatórias/epidemiologia , Prostatectomia , Neoplasias da Próstata/cirurgia , Estudos Retrospectivos , Taxa de Sobrevida , Reação TransfusionalRESUMO
Granulomatous slack skin is an uncommon cutaneous T-helper cell lymphoma closely related to mycosis fungoides. To the best of our knowledge this disease has not been previously described in children. We report on an 11-year-old boy who presented with painless slack skin masses in the neck, right axilla and arm, anterior wall of the abdomen, both inguinal regions, and the malleolar and dorsal aspects of the feet. The disease started 3 years earlier with erythematous lesions on the neck and wrists. Histologic examination of a specimen from the abdominal mass revealed an extensive lymphoid infiltrate with scattered multinucleated giant cells extending from the papillary dermis to the subcutis. The lymphoid cells showed the following immunophenotype: CD43+ (MT1), CD45+, CD45RO+, CD20-. The phenotype of the giant cells was lysozyme positive, CD68+ and Mac387-. The tumoral lymphoid cells had clonal rearrangement for the gene of the beta chain of the T-cell receptor (C beta TCR). The disease could be controlled with systemic glucocorticoids. Due to the presence of many histiocytes arranged in aggregates in the papillary and mid-dermis, this case was initially considered to be a cutaneous form of histiocytosis. We recommend deep and extensive biopsies in patients with slack skin disease.
Assuntos
Linfoma Cutâneo de Células T/patologia , Neoplasias Cutâneas/patologia , Pele/patologia , Criança , Humanos , MasculinoAssuntos
Anestesia Geral , Síndrome do QT Longo/etiologia , Prolapso da Valva Mitral/complicações , Adolescente , Complexos Cardíacos Prematuros/tratamento farmacológico , Humanos , Complicações Intraoperatórias/tratamento farmacológico , Complicações Intraoperatórias/prevenção & controle , Isoproterenol/uso terapêutico , Lidocaína/uso terapêutico , Síndrome do QT Longo/classificação , Masculino , Mandíbula/cirurgia , Prolapso da Valva Mitral/diagnóstico , Cuidados Pré-Operatórios , Fatores de RiscoRESUMO
We describe the histological, immunohistochemical, and ultrastructural findings of a cutaneous tumour composed of ganglion cells, without any other proliferating component. As ganglion cells are not normal components of the skin, we propose the term "ganglion cell choristoma" for this lesion. The differential diagnosis of related lesions such as cutaneous ganglioneuroma, well-differentiated metastases from neuroblastoma, autonomic ganglia entrapped by neurofibroma, and reactive processes, and the possible histogenesis of ganglion cell choristoma are discussed.
Assuntos
Coristoma/patologia , Gânglios/patologia , Neoplasias Cutâneas/patologia , Adolescente , Coristoma/química , Coristoma/ultraestrutura , Diagnóstico Diferencial , Gânglios/química , Gânglios/ultraestrutura , Ganglioneuroma/diagnóstico , Ganglioneuroma/patologia , Humanos , Imuno-Histoquímica , Masculino , Microscopia Eletrônica , Neuroblastoma/diagnóstico , Neuroblastoma/patologia , Neurofibroma/diagnóstico , Neurofibroma/patologia , Proteínas de Neurofilamentos/análise , Fosfopiruvato Hidratase/análise , Neoplasias Cutâneas/química , Neoplasias Cutâneas/ultraestrutura , Terminologia como AssuntoRESUMO
Renal oncocytoma is an uncommon tumor. At least 203 such cases have been reported. This urologic condition represents a diagnostic difficulty and because its natural history has not been elucidated, its treatment remains a controversy. Two recent cases of renal oncocytoma seen at our Urology Service prompted us to review the literature and analyze the diagnostic methods, therapeutic approach and its prognosis.